Intervention not reported
Progression‐free survival1 · Patients with advanced non‐small cell lung cancer
The intervention showed no clear difference in progression‐free survival1 (low certainty).
1 finding from 1 review
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy‐naive advanced non‐small cell lung cancer 2014 · Cochrane Headline outcomes onlyHR 0.91 [0.83, 1]4 studies · 2018 participantsLow